African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women

NOTE.Comparisons were made excluding unknowns.Percentages may not add up to 100 due to rounding.Abbreviations: PST, primary systemic therapy; A, doxorubicin; C, cyclophosphamide; T, docetaxel; P, paclitaxel; pCR, pathological complete response.*Total number of tumors ϭ 40.Two women had synchronous tumors (one white woman with a stage I and II tumors, and one other woman with stage II and III tumors).†P values were obtained using Fisher's exact test, exact 2 test, or Wilcoxon rank sum test, as appropriate.‡One woman had progressive disease and metastases while on primary systemic therapy.